XXII

22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders

Retrieved on: 
Thursday, April 28, 2022
Smoke, Solution, Adult, XXII, Keygen, Pacific Century Group, Nicotine, Genetic engineering, Biomass, Plant, Time, Breeding, Tobacco, Smokeless tobacco, Nasdaq, MRTP, Letter, FDA, The Non-GMO Project, IP, Gene editing, GLOBE, Death, Beer, Food, Forward-looking statement, RNC, Disease, Century, Company, Intellectual property, Annual report, Exercise, Commissioner of Food and Drugs, Smoking, Research, Genetics, Menthol, Industry, Regulation of tobacco by the U.S. Food and Drug Administration, Health, Smoker, Media

---

Key Points: 
  • BUFFALO, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced that the Company has issued its annual letter to shareholders as part of 22nd Centurys 2021 Annual Report.
  • In addition, 22nd Century Group will be hosting its annual meeting of stockholders on Thursday, June 16, 2022, at 10 a.m.
  • In closing, I thank you for your continued support of 22nd Century and its initiatives and look forward to our continued progress in these exciting markets.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference

Retrieved on: 
Wednesday, April 27, 2022
Genetic engineering, RNC, Media, Plant, Pacific Century Group, Century, GLOBE, Death, Tobacco, Conference, XXII, MRTP, Nasdaq, Company, Smoking, Solution, Forward-looking statement, Nicotine, FDA, Disease, Health

Institutional investors participating in the conference can request a meeting with management through their Alliance Global Partners representative, or by contacting 22nd Century Groups investor relations team via [email protected] .

Key Points: 
  • Institutional investors participating in the conference can request a meeting with management through their Alliance Global Partners representative, or by contacting 22nd Century Groups investor relations team via [email protected] .
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.
  • The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021.
  • Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements.

The Washington Commanders Announce the Launch of Washington Branded, An In-House Creative Entity Designed to Develop Authentic and Engaging Offerings for Fans and Partners

Retrieved on: 
Wednesday, April 20, 2022
NFL, National Football League, Marketing, Commander, Walter Payton, XXVI, 1964 NFL Draft, Business operations, List of halls and walks of fame, Technology, Social media, FedExField, Method, Pro Football Hall of Fame Game, History, Digital, Financial Times and McKinsey Business Book of the Year Award, Multimedia, Industry, Sport, Partnership, Team, Super Bowl XVII, View, World championship, Video game, Management, Mobile phone, MD, XXII

LANDOVER, Md., April 20, 2022 /PRNewswire/ -- Today the Washington Commanders have established an in-house branded entertainment studio called Washington Branded. This new creative arm will offer partners two collaborative options – original content and branded content – focused on the creation of cross-platform content that fans and wider audiences see as entertainment they genuinely want to watch. With talent from a variety of brand, entertainment, media, sports and film backgrounds, Washington Branded is set to stand apart from other similar entities in the industry.

Key Points: 
  • LANDOVER, Md., April 20, 2022 /PRNewswire/ --Today the Washington Commanders have established an in-house branded entertainment studio called Washington Branded.
  • With talent from a variety of brand, entertainment, media, sports and film backgrounds, Washington Branded is set to stand apart from other similar entities in the industry.
  • "In today's fragmented media world, where technology enables consumers to control what, where and when they experience their entertainment, traditional methods of reaching audiences aren't enough.
  • Washington Commanders' Football Operations are headquartered at the Inova Sports Performance Center in Ashburn, Virginia, and their Business Operations are headquartered at FedExField.

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022

Retrieved on: 
Thursday, April 14, 2022
Genetic engineering, Investor relations, RNC, Media, Plant, Software, Pacific Century Group, Century, GLOBE, Death, Q&A, Tobacco, XXII, MRTP, Company, Nasdaq, Smoking, Solution, Webcast, Forward-looking statement, Nicotine, R. J. Reynolds Tobacco Company, FDA, Disease, Health, Public relations

22nd Century will report the Companys first quarter 2022 results in a press release at 6:00 AM ET the same day.

Key Points: 
  • 22nd Century will report the Companys first quarter 2022 results in a press release at 6:00 AM ET the same day.
  • Following prepared remarks by management and slide presentation, the Company will host a Q&A session, during which management will accept questions from interested analysts.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.
  • Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements.

First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland

Retrieved on: 
Wednesday, April 13, 2022
Center, Circle K, Smoke, NIDA, Genetic engineering, Mayo Clinic, RNC, Marketing, Plant, Population, CDC, Centers for Disease Control and Prevention, Chicago Medical Society, Adult, National Cancer Institute, Regulation of tobacco by the U.S. Food and Drug Administration, Research, Ageing, National Institute on Drug Abuse, MD, Academy of Technological Sciences of Ukraine, Taste, Food, Pacific Century Group, Century, Smokeless tobacco, GLOBE, Death, National, Patient, Directory, Tobacco, Burns, XXII, MRTP, Nasdaq, Company, Smoker, Food and Drug Administration, Language, Smoking, Solution, Forward-looking statement, National Institute, Nicotine, Smell, VLN, FDA, Disease, NCI, Health, Johns Hopkins University, University, Chicago metropolitan area

CHICAGO, April 13, 2022 (GLOBE NEWSWIRE) -- The first and only combustible tobacco cigarette containing minimal to non-addictive levels of nicotine and authorized by the U.S. Food and Drug Administration (FDA) to help adult smokers smoke less is now available through a national pilot exclusively in select Chicagoland Circle K stores.

Key Points: 
  • Additionally, the FDA requires each package of VLN to prominently display the evidence based claim Helps you smoke less.
  • If the FDA says this reduced nicotine cigarette will help people smoke less, then as doctors its something we need to consider for patients.
  • When choosing Chicagoland for the pilot, 22nd Century noted smokers are found within every segment of the population, many of whom are looking for alternatives.
  • The CDC estimates 15.5% of Illinois adults aged 18 years or older smoke cigarettes, higher than the national average of 12.5%, according to 2018 state and 2020 national statistics.

Washington Commanders Announce Three-Year Audio Partnership with iHeartMedia D.C.

Retrieved on: 
Tuesday, April 12, 2022
DMV, NBA Sixth Man of the Year Award, Commander, NFL, Pro Football Hall of Fame Game, Super Bowl XVII, WWDC-FM, IHeartMedia, Disc jockey, Partnership, List of halls and walks of fame, Walter Payton, Multimedia, National Football League, Football, Training camp, DC, Radio, WMZQ-FM, IHeartRadio, Sport, FedExField, WBIG-FM, 1964 NFL Draft, Business operations, Nasdaq, WASH-FM, Team, WASH, World championship, XXVI, History, Music, D.C, XXII, MD

LANDOVER, Md., April 12, 2022 /PRNewswire/ -- Today the Washington Commanders announced a new three-year partnership deal with iHeartMedia D.C. to be the team's exclusive radio broadcast partner. Beginning in the 2022 season, live gameday broadcasts will run on iHeartMedia's BIG 100.3 FM and be featured on the station's website and on the iHeartRadio app, iHeartMedia's free all-in-one digital music, podcasting and live streaming radio service. This new partnership will expand the team's reach across the DMV, giving more fans the ability to listen and engage with the Washington Commanders on a daily basis and helping to grow the team's fanbase in the region.

Key Points: 
  • "We are excited to team up with iHeartMedia as we enter our inaugural season as the Washington Commanders," said Jason Wright, President of the Washington Commanders.
  • "The Washington Commanders are an iconic brand that we are excited to join forces with," said Kevin LeGrett, President of iHeartMedia Sports.
  • "iHeartMedia DC is thrilled to announce the inaugural broadcast partnership with the Washington Commanders," said Aaron Hyland Region President iHeartMedia.
  • The partnership with the Commanders represents iHeartMedia's 18th National Football League partnership.

22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer

Retrieved on: 
Monday, April 11, 2022
Disease, Pacific Century Group, Company, University, Monsanto, University of Nebraska–Lincoln, Nicotine, Leadership, Breeding, Forward-looking statement, Death, Genetics, XXII, University of Wisconsin–Madison College of Agricultural and Life Sciences, Research, Tobacco, Plant, University of Nebraska Medical Center, Health, Economics, Technology, Seed, Media, Nasdaq, Century, MBA, Smoking, Crop protection, GLOBE, MRTP, Soybean, Solution, RNC, FDA, Genetic engineering, Bayer, IP, Agriculture, Science, Agriculture

BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced the appointment of Dr. Calvin Treat as Chief Scientific Officer, effective May 23, 2022. In this new role, Dr. Treat will lead the expanding scientific, research and technological operations of the company, leveraging its expertise, IP, and partnerships across all three of its alkaloid plant franchises toward becoming a global leader in specialty plant science.

Key Points: 
  • BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced the appointment of Dr. Calvin Treat as Chief Scientific Officer, effective May 23, 2022.
  • Treat brings a wealth of plant-based biotechnology and crop technology experience to 22nd Century at a pivotal time when we are rapidly expanding our global capabilities across all three of our alkaloid plant franchises tobacco, hemp/cannabis, and hops, said James A. Mish, chief executive officer of 22nd Century Group.
  • Treat has spent his career at the largest plant science names in the world, leading their innovations on major crops like corn, soybeans, and cotton.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing

Retrieved on: 
Monday, March 28, 2022
Smoke, Pacific Century Group, Company, Directory, Nicotine, Death, Adult, Centers for Disease Control and Prevention, Tobacco, Plant, Ageing, Statistics, CEO, Health, Food, Smoker, Food and Drug Administration, Nasdaq, Century, Smoking, GLOBE, Center, MRTP, Solution, RNC, FDA, Smokeless tobacco, Genetic engineering, Disease, Chicago metropolitan area, XXII

VLN cigarettes are scientifically shown to help adult smokers smoke less, said James A. Mish, CEO of 22nd Century Group.

Key Points: 
  • VLN cigarettes are scientifically shown to help adult smokers smoke less, said James A. Mish, CEO of 22nd Century Group.
  • Illinois is the second most expensive cigarette retail market in the United States.
  • 22nd Century is pursuing registration in all 50 states as it readies for national launch following its Chicagoland pilot program.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15

Retrieved on: 
Wednesday, March 9, 2022
Smoking, Century, Nasdaq, RNC, Company, Research, FDA, CFO, MRTP, Conference, Ritz-Carlton Atlantic City, Laguna Niguel, California, Plant, XXII, Health, Pacific Century Group, Roth Capital Partners, Nicotine, GLOBE, Media, Solution, Death, Disease, Genetic engineering, CEO, Forward-looking statement, Tobacco

Roth Agricultural Technology Analyst Brian Wright today initiated research coverage on 22nd Century Group.

Key Points: 
  • Roth Agricultural Technology Analyst Brian Wright today initiated research coverage on 22nd Century Group.
  • Roth Capital events are intended for prospective and existing Roth Capital clients.
  • To request a meeting, please contact your Roth Capital representative, or by contacting 22nd Century Groups investor relations team via [email protected] .
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

22nd Century Group Announces South Korea as First VLN® International Market

Retrieved on: 
Monday, February 28, 2022
GLOBE, Nicotine, Health, Plant, Smoke, Government, Death, Genetic engineering, Smoker, Media, Man, Taste, Company, National, Sale, Pacific Century Group, Smoking, XXII, Disease, Woman, Adult, Food, Smell, Tobacco, MRTP, RNC, FDA, Nasdaq, Forward-looking statement, Solution, Century, Food and Drug Administration

South Korea is an ideal international launch market in many ways, with a high smoking rate among developed countries and a government strongly committed to smoking harm reduction.

Key Points: 
  • South Korea is an ideal international launch market in many ways, with a high smoking rate among developed countries and a government strongly committed to smoking harm reduction.
  • We are excited to make VLN reduced nicotine content products available in South Korea to help break the nicotine addiction cycle and support this important effort.
  • In addition to its first international launch of VLN reduced nicotine content cigarettes in the more than $800 billion global tobacco market, 22nd Century Group is actively moving forward to launch VLN in the $80 billion U.S. tobacco market.
  • The U.S. FDA authorized 22nd Centurys VLN reduced nicotine content cigarette products on December 23, 2021.